Noncolorectal Gastrointestinal cancers (GI cancers) are a significant public health problem.
Current conventional therapeutic options, such as surgery, chemotherapy, radiotherapy, and targeted therapies, are not always highly effective in noncolorectal GI cancer patients, and the overall mortality remains a major issue.